The integrin α4β1 (or VLA-4), which is considered as a marker of activated and proliferating LECs in human and murine tumors (81), is activated by the VEGF-C/PI3Kα pathway in LECs to promote lymphangiogenesis and tumor metastasis in LNs. This evidence concerns the gene VEGFC and neoplasm.